Evidence map›Paper›PMID 38028641›Full record

ReviewJournal of intensive medicine2023

Severe

Despoina Koulenti, Marios Karvouniaris, Elisabeth Paramythiotou, Nikolaos Koliakos, Nikolaos Markou, Paschalis Paranos, Joseph Meletiadis, Stijn Blot

Open access · goldAbstract readReview
In one paragraph

Review in Journal of intensive medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Overview of Risk Factors and Diagnosis of Invasive Candidiasis.Journal of fungi (Basel, Switzerland) · 2026
    Review
  2. Observational
  3. Article
  4. UnderstandingJournal of medical microbiology · 2026
    Review
  5. Article
  6. Article
  7. Observational
  8. Genome sequences of six clinical isolates ofMicrobiology resource announcements · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Gut Mycobiome Changes During COVID-19 Disease.Journal of fungi (Basel, Switzerland) · 2025
    Article
  13. Isolation ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. The Emergence ofInfection and drug resistance · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Despoina KoulentiSecond Critical Care Department, Attikon University Hospital, Athens, Greece.
Marios KarvouniarisIntensive Care Unit, ACHEPA University Hospital, Thessaloniki, Greece.
Elisabeth ParamythiotouSecond Critical Care Department, Attikon University Hospital, Athens, Greece.
Nikolaos KoliakosSecond Critical Care Department, Attikon University Hospital, Athens, Greece.
Nikolaos MarkouICU of Latseio Burns Centre, General Hospital of Elefsis 'Thriasio', Athens, Greece.
Paschalis ParanosClinical Microbiology Laboratory, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
Joseph MeletiadisClinical Microbiology Laboratory, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
Stijn BlotUQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
National and Kapodistrian University of Athens · GRThe University of Queensland · AUUniversity General Hospital Attikon · GRAHEPA University Hospital · GRThriasio General Hospital of Elefsina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The frequency of co-infections with bacterial or fungal pathogens has constantly increased among critically ill patients with coronavirus disease 2019 (COVID-19) during the pandemic. Candidemia was the most frequently reported invasive fungal co-infection. The onset of candidemia in COVID-19 patients was often delayed compared to non-COVID-19 patients. Additionally,

Indexed as

AntifungalsCandida aurisCandida spp.CandidiasisCOVID-19Critical illness

Identifiers

PMID38028641
PMCPMC10658040
OpenAlexW4386391869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.